Charles River Laboratories International

Charles River Laboratories, Inc., is a corporation specializing in a variety of pre-clinical and clinical laboratory services for the pharmaceutical, medical device, and biotechnology industries. The Company also supplies assorted biomedical products and research and development outsourcing services for use in the pharmaceutical industry. Charles River Laboratories' customers include pharmaceutical and biotechnology companies as well as academic institutions and government research centers. 

Type
Public
HQ
Wilmington, US
Founded
1947
Size (employees)
11,800 (est)+8%
Website
criver.com
Charles River Laboratories International was founded in 1947 and is headquartered in Wilmington, US
Report incorrect company information

Charles River Laboratories International Office Locations

Charles River Laboratories International has an office in Wilmington
Wilmington, US (HQ)
251 Ballardvale Street
Show all (1)
Report incorrect company information

Charles River Laboratories International Financials and Metrics

Charles River Laboratories International Financials

Charles River Laboratories International's revenue was reported to be $1.68 b in FY, 2016 which is a 23.3% increase from the previous period.
USD

Revenue (Q1, 2018)

494 m

Gross profit (Q1, 2018)

425.3 m

Gross profit margin (Q1, 2018), %

86.1%

Net income (Q1, 2018)

53.2 m

EBIT (Q1, 2018)

67.8 m

Market capitalization (23-May-2018)

5.1 b

Closing share price (23-May-2018)

106.5

Cash (31-Mar-2018)

187.8 m
Charles River Laboratories International's current market capitalization is $5.1 b.
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

1.2 b1.3 b1.4 b1.7 b

Revenue growth, %

11%5%23%

Cost of goods sold

264 m277 m

Gross profit

1.1 b1.4 b
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018

Revenue

292.1 m299.4 m341.2 m327.6 m320.4 m339.6 m349.5 m354.9 m434.1 m425.7 m445.8 m469.1 m464.2 m494 m

Cost of goods sold

70.3 m66.6 m67.6 m65.2 m64.4 m62.6 m66.2 m66.8 m68.2 m69.3 m67.2 m68.8 m67.7 m68.7 m

Gross profit

221.8 m232.8 m273.6 m262.3 m256 m276.9 m283.2 m288.1 m365.9 m356.4 m378.5 m400.4 m396.6 m425.3 m

Gross profit Margin, %

76%78%80%80%80%82%81%81%84%84%85%85%85%86%
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

155.9 m160 m117.9 m117.6 m

Accounts Receivable

220.6 m258 m270.1 m364.1 m

Inventories

89.4 m89 m93.7 m95.8 m

Current Assets

552.6 m606.9 m559.2 m656.8 m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018

Cash

130.5 m169.9 m117 m130.7 m151.9 m150.8 m74 m157.4 m154.6 m105.7 m131.5 m116.5 m123.6 m187.8 m

Accounts Receivable

224.3 m240 m274.5 m275 m265.4 m277.4 m288.8 m287.2 m345.5 m359.7 m383.7 m398.5 m422.3 m440.1 m

Inventories

87.1 m91.7 m92.6 m92.7 m86.1 m90 m98.1 m97.1 m98.1 m99.4 m98.5 m104.7 m107.4 m119 m

Current Assets

547.8 m590.7 m592.7 m606 m614.1 m629.6 m578.7 m637.4 m701.5 m654.6 m700.1 m738.1 m782.4 m843.3 m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

104.2 m128.2 m151.1 m156.4 m

Depreciation and Amortization

96.6 m96.4 m24.2 m41.7 m

Inventories

(1.6 m)(3 m)3.4 m(4 m)

Accounts Payable

(7.1 m)4.6 m1.2 m22.1 m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q3, 2017Q1, 2018

Net Income

31.2 m32.4 m35.8 m32.4 m31.6 m49.2 m37.9 m37.5 m35.6 m38 m47 m53 m53.2 m

Depreciation and Amortization

5.3 m5.7 m6.4 m6.4 m11.2 m11.8 m10.7 m33.2 m

Inventories

90 m98.1 m97.1 m98.1 m99.4 m98.5 m107.4 m(3.5 m)

Accounts Payable

33 m31.6 m43.9 m66.2 m65.8 m61 m66.2 m(1.1 m)
USDY, 2018

Financial Leverage

2.6 x
Show all financial metrics

Charles River Laboratories International Acquisitions / Subsidiaries

Acquired CompanyDateDeal Size
MPI Research (1 k)February 13, 2018$800 m
Report incorrect company information